trending Market Intelligence /marketintelligence/en/news-insights/trending/vlyi662AT0k7RP3LelPbIQ2 content esgSubNav
In This List

Northwest Biotherapeutics issues common stock, warrants in private placement

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Northwest Biotherapeutics issues common stock, warrants in private placement

Northwest Biotherapeutics Inc. sold 5.0 million common shares at 20 cents apiece to an unaffiliated investor.

The company also issued to the investor 2.5 million class D warrants exercisable at 23 cents per share for a period of two years, and 2.5 million class D warrants exercisable at 30 cents per share for a period of two years, for an aggregate of $1.0 million.